CTC BIO, INC. Logo

CTC BIO, INC.

Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.

060590 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄첨단산업1로 27 금강펜테리움IX타워 A동 901호, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CTC BIO, Inc. is a pharmaceutical company specializing in the development, manufacturing, and distribution of products for both human and animal health. The company leverages core expertise in microbial fermentation and coating technology. Its Animal Health division produces a range of veterinary medicines, such as antibiotics and coccidiostats, along with feed additives, enzymes, and probiotics. The Human Health division offers various pharmaceuticals, functional foods, and advanced probiotics. With a focus on innovation, CTC BIO serves both domestic and international markets, committed to enhancing health for humans and animals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 82.3 KB
2025-09-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.9 KB
2025-08-12 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-08-12 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-25 00:00
Capital/Financing Update
단기차입금증가결정
Korean 8.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.7 MB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.7 KB
2025-04-16 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.4 KB
2025-04-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.9 KB
2025-04-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-04-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 92.9 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.6 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 587.2 KB
2025-03-14 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 20.4 KB

Automate Your Workflow. Get a real-time feed of all CTC BIO, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CTC BIO, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.